Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-07-04

Clinical Trial Update: A Diabetes Study to Treat A Population Previously Not at Target [Phase 4]

View source ↗

Summary

AstraZeneca conducted a Phase 4 trial in Type 2 diabetes focusing on patients not at target. The results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2011-07-04